Altered cortical excitability in obsessive-compulsive disorder

Neurology

Volumn 54, Issue 1, 2000, Pages 142-147

  Greenberg, Benjamin D ^a,b   Ziemann, U ^a   Cora Locatelli G ^a   Harmon, A ^a   Murphy, D L ^a   Keel, J C ^a   Wassermann, Eric M ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NONE   (United States)

Author keywords

Basal ganglia; Intracortical inhibition; Obsessive compulsive disorder; Transcranial magnetic stimulation

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CLINICAL ARTICLE; CONDITIONING; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; EXCITABILITY; FACILITATION; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; MOTOR CORTEX; OBSESSION; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; TIC; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0033982173     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.1.142     Document Type: Article

References (35)

1. Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry 1986;43:1180-1182.
2. Alsobrook JP, Pauls DL. The genetics of Tourette's syndrome. Neurol Clin 1997;15:381-393.
3. Leckman JF, Peterson BS, Pauls DL, Cohen DJ. Tic disorders. Psychiatr Clin North Am 1997;20:839-861.
4. Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:681-689.
5. Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996;53:109-113.
6. Rapoport JL, Wise SP. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull 1988;24:380-384.
7. Rauch S, Baxter L. Neuroimaging in obsessive-compulsive disorder and related disorders. In Jenike MA, Baer L, Minichiello WE, eds.: Obsessive-compulsive disorders: practical management. 3rd ed. 1998:289-318.
8. Rauch S, Cora-Locatelli G, Greenberg B. Pathogenesis of obsessive-compulsive disorders. In: Stein DJ, Hollander E, eds. Textbook of anxiety disorders. Washington, DC: American Psychiatric Press, (in press)
9. Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol 1991;81:257-262.
10. Ziemann U, Netz J, Szelenyi A, Homberg V. Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex. Neurosci Lett 1993:156:167-171.
11. Ziemann U, Paulus W, Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997;154:1277-1284.
12. Garvey M, Hallet M, Ziemann U. Children with Sydenham chorea have decreased cortical postexcitatory inhibition. Mov Disord 1998;13(suppl):231. Abstract.
13. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol (Lond) 1993;471: 501-519.
14. Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol (Lond) 1996;496:873-881.
15. Di Lazzaro V, Restuccia D, Oliviero A, et al. Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits. Exp Brain Res 1998; 119:265-268.
16. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996;40: 367-378.
17. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996;109:127-135.
18. Ziemann U, Steinhoff BJ, Tergau F, Paulus W. Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 1998;30:11-30.
19. Ziemann U, Chen R, Cohen L, Hallet M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998;51:1320-1324.
20. Liepert J, Schwenkreis P, Tegenthoff M, Malin JP. The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm 1997;104:1207-1214.
21. Greenberg B, Ziemann U, Harmon A, Murphy D, Wassermann E. Reduced intracortical inhibition in obsessive-compulsive disorder on transcranial magnetic stimulation. Lancet 1998;352:881-882.
22. Ridding MC, Sheean G, Rothwell JC, Inzelberg R, Kujirai T. Changes in the balance between motor cortical excitation and inhibition in focal, task-specific dystonia. J Neurol Neurosurg Psychiatry 1995;59:493-498.
23. Ridding MC, Rothwell JC. Stimulus/response curves as a method of measuring motor cortical excitability in man. Electroencephalogr Clin Neurophysiol 1997;105:340-344.
24. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995;37:181-188.
25. Rosenberg DR, Keshavan MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 1998;43:623-640.
26. Broocks A, Thiel A, Angerstein D, Dressler D. Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. Am J Psychiatry 1998;155:555-557.
27. Tegenthoff M, Vorgerd M, Juskowiak F, Roos V, Malin J-P. Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington's disease. Electroencephalogr Clin Neurophysiol 1996;101:298-303.
28. Rauch SL, Savage CR. Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. Psychiatr Clin North Am 1997;20:741-768.
29. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
30. Aylward EH, Harris GJ, Hoehn-Saric R, Barta PE, Machlin SR, Pearlson GD. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiatry 1996;53:577-584.
31. Cora-Locatelli G, Greenberg BD, Martin J, Murphy DL. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder. J Clin Psychiatry 1998;59: 480-481. Letter.
32. Ziemann U, Winter M, Reimers CD, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology 1997;49:1292-1298.
33. Triggs WJ, MacDonnell RAL, Cros D, Chiappa KH, Shahani BT, Day BJ. Motor inhibition and excitation are independent effects of transcranial magnetic stimulation. Ann Neurol 1992;32:345-352.
34. Ikoma K, Samii A, Mercuri B, Wassermann EM, Hallett M. Abnormal cortical motor excitability in dystonia. Neurology 1996;46:1371-1376.
35. Filipovic S, Ljubisavljevic M, Svetel M, Milanovic S, Kacar A, Kostic V. Impairment of cortical inhibition in writer's cramp as revealed by changes in electromyographic silent period after transcranial magnetic stimulation. Neurosci Lett 1997; 222:167-170.